Ordering Recommendation

Monitor HBV therapy; order along with HBV DNA, HBV surface antigen, HBV surface antibody, and HBe antigen.

Methodology

Qualitative Chemiluminescent Immunoassay

Performed

Sun-Sat

Reported

Within 24 hours

New York DOH Approval Status

This test is New York DOH approved.

Specimen Required

Patient Preparation
Collect

Serum separator tube (SST). Also acceptable: Lavender (EDTA) or dark green (lithium heparin).

Specimen Preparation

Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Specimens that are heat-inactivated, grossly hemolyzed, grossly icteric, grossly lipemic specimens, or specimens containing particulate material.

Remarks
Stability

After separation from cells: Ambient: Unacceptable; Refrigerated: 7 days; Frozen: 30 days (avoid repeated freeze/thaw cycles)

Reference Interval

Negative

Interpretive Data

This assay should not be used for blood donor screening, associated reentry protocols, or for screening human cell, tissues, and cellular and tissue-based products (HCT/P).

Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

86707

Components

Component Test Code* Component Chart Name LOINC
0020095 Hepatitis Be Antibody 13953-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Chronic Hepatitis Profile
  • Chronic Hepatitis, HBeV
  • Hepatitis Be Ab, Antibody to Hepatitis Be antigen
  • Hepatitis Be Antibody
  • Hepatitis Be Antigen and Hepatitis Be Antibody, Serum
Hepatitis Be Virus Antibody